Li, S., Kong, Y., Si, L., Chi, Z., Cui, C., Sheng, X., & Guo, J. (2014). Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma. BioMed Central.
Chicago ZitierstilLi, Siming, Yan Kong, Lu Si, Zhihong Chi, Chuanliang Cui, Xinan Sheng, und Jun Guo. Phosphorylation of MTOR and S6RP Predicts the Efficacy of Everolimus in Patients With Metastatic Renal Cell Carcinoma. BioMed Central, 2014.
MLA ZitierstilLi, Siming, et al. Phosphorylation of MTOR and S6RP Predicts the Efficacy of Everolimus in Patients With Metastatic Renal Cell Carcinoma. BioMed Central, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.